What did @adaclipsadmin actually say?
The creator describes a patient case involving trenbolone ("tren") withdrawal after a cycle that included testosterone enanthate 400mg weekly and Anavar 40mg daily. The patient experienced "full-blown ED" and what sounds like a depressive spiral after stopping tren. The described recovery protocol included hCG (750 IU every other day, tapered to 250 IU), cabergoline, and sertraline (Zoloft). The creator claims "it worked" after a few weeks.
This is a harm-reduction case presentation, not a clinical trial. The creator is clearly a physician describing a patient interaction, which adds some credibility to the framing. But a single anecdote is not evidence of a protocol, and several terms in the transcript are garbled enough to raise questions about what was actually prescribed and why.
Does the science back this up?
Partially, yes. Trenbolone is a 19-nor synthetic androgen with no approved human medical use. What we know from pharmacology and limited case literature is concerning enough to take the withdrawal claim seriously.
Trenbolone suppresses the hypothalamic-pituitary-gonadal (HPG) axis aggressively, more so than testosterone alone, and does not aromatize to estrogen. This creates a post-cycle hormonal environment that is low in both testosterone and estrogen, which can produce significant depression and sexual dysfunction (Kanayama et al., 2015, Drug and Alcohol Dependence). The use of hCG to stimulate endogenous testosterone production post-cycle has biological rationale: LH receptors in the testes respond to hCG similarly to LH (Coviello et al., 2004, Journal of Clinical Endocrinology and Metabolism).
Cabergoline targets dopamine D2 receptors and is typically used to suppress prolactin. Some 19-nor androgens, including trenbolone, may elevate prolactin in certain users, which contributes to sexual dysfunction and mood issues. However, evidence for tren-specific prolactin elevation in humans is thin and mostly anecdotal.
Sertraline for post-cycle depression has some indirect support: hypogonadism-associated depression responds to androgen restoration, but SSRIs can bridge the gap during recovery. That said, SSRIs can worsen sexual dysfunction in the short term, which is a real concern in this context.
What did they get wrong (or right)?
The creator gets the broad strokes right. Trenbolone is genuinely harsh, post-cycle suppression is real, and using hCG plus dopaminergic support while the HPG axis recovers is not an unreasonable clinical approach. Giving credit where it's due: most social media content on tren dismisses the psychological effects entirely. Naming "short-fuse," hypersexuality, and personality change as documented side effects is accurate.
What's sloppy: the dosing details are murky. "8Cg, 750 every other day" appears to be hCG, but the transcript is unclear. The cabergoline dose is never stated, which matters because cabergoline has a narrow therapeutic range and psychiatric side effects at higher doses, including impulse control disorders and, rarely, psychosis (Pontone et al., 2006, Psychosomatics).
Also, framing this as a validated "recovery protocol" overstates the evidence. There are no randomized controlled trials on tren-specific post-cycle recovery. This is expert-guided harm reduction, not established medicine. Calling it a protocol implies replicability that the data does not support.
What should you actually know?
Trenbolone has no approved human use. It is a veterinary androgen, and any human use carries compounded legal and health risks. The HPG suppression from tren cycles can last months beyond the cycle itself. A 2014 study by Pope et al. in JAMA Psychiatry found that long-term AAS users showed significant HPG axis suppression that persisted well after cessation, sometimes requiring medical intervention.
The psychiatric effects are not trivial. Rage, depression, and hypersexuality are documented in the literature, not just gym lore (Thiblin and Petersson, 2005, Sports Medicine). Anyone experiencing post-cycle mood crashes or sexual dysfunction should seek evaluation from a physician familiar with androgen pharmacology, not attempt to self-administer cabergoline or SSRIs based on a TikTok case study.
If you are on a TRT protocol through a legitimate telehealth provider, stacking illicit androgens like trenbolone is outside the scope of that care and potentially dangerous. The interactions between therapeutic testosterone and high-dose illicit androgens are not studied in controlled settings.
Bottom line
This video is more medically grounded than most tren content online. But it is one physician describing one patient case, not a peer-reviewed protocol. The biological rationale for the approach is defensible. The leap to calling it a recovery protocol is not.